Market Research

EUROPE BOTULINUM TOXIN MARKET 2021-2028

Best Price Guarantee Length Publisher Published Date SKU
from $1,500 125 Pages Triton Market Research June, 2021 TRTN16847101
Best Price Guarantee
Price from $1,500
Length 125 Pages
Publisher Triton Market Research
Published Date June, 2021
SKU TRTN16847101

EUROPE BOTULINUM TOXIN MARKET 2021-2028

MARKET OUTLOOK

Triton’s report has determined the botulinum toxin market in Europe to progress at a CAGR of 5.58% over the forecasting duration 2021-2028. The United Kingdom, Germany, France, Spain, Italy, Russia, and Rest of Europe together constitute the market in this region.

The growth in the population and the rise in people’s education & financial levels have enhanced the demand for healthcare services in Spain. As per estimates, close to 247,223 non-invasive aesthetic procedures were performed in the country in 2016. Out of these, 81,833 were botulinum toxin-based procedures. Botulinum toxin-based products (Botox, Xeomin, and Dysport) are gaining popularity in Spain, and it is expected to increase even more in the future. The increase in collaborations/agreements between companies and the growing focus of bigger players on product launches are expected to aid the growth of the Spanish market in the coming years.

Italy is the fourth-largest market for cosmetic and aesthetic procedures in Europe. 1 out of every 10 patients applying for cosmetic surgery in the country is a tourist. Owing to the top-notch medical facilities and services provided here, people from neighboring and other countries, mainly those from Switzerland, Romania, and Russia, flock to Italy for cosmetic treatments. In 2018, around 542,752 non-invasive cosmetic procedures were performed in the country, with 181,472 being botulinum toxin-based procedures. All these factors are expected to fuel the growth of the Italian botulinum toxin market in the projected phase.

COMPETITIVE OUTLOOK

Some of the established names in the botulinum toxin market are US WorldMeds LLC, Revance Therapeutics Inc, Galderma Pharma SA (Acquired by EQT), Merz Pharma, and Ipsen Pharma.


1. EUROPE BOTULINUM TOXIN MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. KEY INSIGHTS
2.1.1. SURGE IN DISPOSABLE INCOME
2.1.2. GROWING NUMBER OF MEN OPTING FOR COSMETIC TREATMENT
2.1.3. DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE
2.2. IMPACT OF COVID-19 ON THE BOTULINUM TOXIN INDUSTRY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS MATRIX
2.5. VENDOR SCORECARD
2.6. KEY MARKET STRATEGIES
2.6.1. NEW PRODUCT LAUNCHES
2.7. MARKET DRIVERS
2.7.1. INCREASING DEMAND FOR AESTHETIC PROCEDURES
2.7.2. EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS
2.8. MARKET RESTRAINTS
2.8.1. ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN
2.8.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
2.8.3. LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS
2.9. MARKET OPPORTUNITIES
2.9.1. INCREASING AGING POPULATION
2.9.2. RISE IN MEDICAL TOURISM
3. EUROPE BOTULINUM TOXIN MARKET – BY TYPE
3.1. TYPE A
3.2. TYPE B
4. EUROPE BOTULINUM TOXIN MARKET – BY APPLICATION
4.1. COSMETIC APPLICATIONS
4.1.1. GLABELLAR LINES
4.1.2. LATERAL CANTHAL LINES (CROW’S FEET)
4.1.3. FOREHEAD LINES
4.1.4. OTHER COSMETIC APPLICATIONS
4.2. NON-COSMETIC APPLICATIONS
4.2.1. DYSTONIA
4.2.2. CHRONIC MIGRAINE
4.2.3. OPHTHALMOLOGIC DISORDERS
4.2.4. OTHER NON-COSMETIC APPLICATIONS
5. EUROPE BOTULINUM TOXIN MARKET – BY END-USER
5.1. HOSPITALS
5.2. CLINICS AND OTHERS
6. EUROPE BOTULINUM TOXIN MARKET – REGIONAL OUTLOOK
6.1. COUNTRY ANALYSIS
6.1.1. UNITED KINGDOM
6.1.2. GERMANY
6.1.3. FRANCE
6.1.4. SPAIN
6.1.5. ITALY
6.1.6. RUSSIA
6.1.7. REST OF EUROPE
7. COMPETITIVE LANDSCAPE
7.1. ABBVIE INC
7.2. EVOLUS INC
7.3. GALDERMA PHARMA SA (ACQUIRED BY EQT)
7.4. HUGEL INC
7.5. IPSEN PHARMA
7.6. MERZ PHARMA
7.7. MEDYTOX INC
7.8. REVANCE THERAPEUTICS INC
7.9. US WORLDMEDS LLC
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY
LIST OF TABLES
TABLE 1: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS MATRIX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF NEW PRODUCT LAUNCHES
TABLE 5: EUROPE BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 6: EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 7: EUROPE BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCES ANALYSIS
FIGURE 2: EUROPE BOTULINUM TOXIN MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE 3: EUROPE BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)
FIGURE 4: EUROPE BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)
FIGURE 5: EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 6: EUROPE BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 7: EUROPE BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)
FIGURE 8: EUROPE BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 11: EUROPE BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 12: EUROPE BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)
FIGURE 14: EUROPE BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 15: EUROPE BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE BOTULINUM TOXIN MARKET, BY END-USER, 2020 & 2028 (IN %)
FIGURE 17: EUROPE BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 18: EUROPE BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 19: EUROPE BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 20: UNITED KINGDOM BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: GERMANY BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: FRANCE BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: SPAIN BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: ITALY BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: RUSSIA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: REST OF EUROPE BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

$1,500
$2,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings